The human papilloma virus (HPV) prophylactic vaccine

Authors

  • Editorial Board South African HPV Advisory Board

Abstract

Carcinoma of the cervix is the most common cancer of women in Africa comprising 23 percent of all reported cancers in women. The incidence rate in South Africa is approximately 35/100 000 women years, one of the highest incidence rates in the world. In the last two decades, the aetiological role of the human papilloma virus (HPV) infection in the development of pre-invasive and invasive lesions of the cervix, vagina and the ano-genital region has been conclusively established. The understanding of the oncogenesis of cervical cancer has improved to such an extent that new technologies to detect persistent HPV infection are available and are becoming part of clinical practice. HPV16 is associated with more than 50% of all invasive cervical carcinomas, HPV18 with 16% and HPV31 with 8%. Protection against the most potent carcinogen is a classic example of primary prevention. HPV6 and 11 cause genital warts.

Downloads

Issue

Vol. 1 No. 2 (2009)

Section

Clinical Guidelines

License

By submitting manuscripts to SAJGO, authors of original articles are assigning copyright to the South African Society of Gynaecologic Oncology (SASGO). Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAJGO for educational and research purposes without obtaining permission.